Docetaxel

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

79 API Suppliers, 41 USDMF, 28 CEP/COS, 10 JDMF, 8 EU WC, 14 KDMF, 15 NDC API, 39 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

87 Drugs in Development

87 Drugs in Development

INTERMEDIATES

14 Intermediate Suppliers

14 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

294 FDF Dossiers, 85 FDA Orange Book, 99 Europe, 4 Canada, 8 Australia, 29 South Africa, 69 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 160MG/8ML (20MG/ML), INJECTABLE;INJECTION - 20MG/ML (20MG/ML), INJECTABLE;INJECTION - 20MG/0.5ML (40MG/ML), INJECTABLE;INJECTION - 80MG/4ML (20MG/ML), INJECTABLE;INJECTION - 80MG/2ML (40MG/ML), INJECTABLE;INJECTION - 160MG/8ML (20MG/ML), INJECTABLE;INJECTION - 20MG/ML (20MG/ML), INJECTABLE;INJECTION - 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 80MG/4ML (20MG/ML), INJECTABLE;INJECTION - 160MG/8ML (20MG/ML), INJECTABLE;INJECTION - 20MG/ML (20MG/ML), INJECTABLE;INJECTION - 80MG/4ML (20MG/ML), INJECTABLE;INJECTION - 20MG/VIAL, INJECTABLE;INJECTION - 80MG/VIAL

RELATED EXCIPIENT COMPANIES

1 Boai NKY Pharmaceuticals Ltd, 3 Nanjing Well Pharmaceutical, 2 Actylis, 2 BASF, 1 Clariant, 1 Finar, 3 Gangwal Chemicals, 1 Nanjing Bold Chemical, 6 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

13 Solubilizers, 7 Parenteral, 7 Topical, 4 Thickeners and Stabilizers, 4 Film Formers & Plasticizers, 4 Emulsifying Agents, 3 Surfactant & Foaming Agents, 2 Rheology Modifiers, 1 API Stability Enhancers, 1 Co-Processed Excipients, 1 Direct Compression, 1 Coating Systems & Additives